Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06692634Not ApplicableNot Yet Recruiting

Effects of End-inspiratory Pause on Ventilation

Role: lead

NCT05281536Not ApplicableCompleted

Effects of Trunk Postural Change on CO2 Removal Efficiency in ARDS Patients: Quasi-experimental Study

Role: lead

NCT04435613Not ApplicableCompleted

Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients

Role: lead

NCT03592056Terminated

Hemidiaphragmatic Paralysis With Diluted Continuous Interscalene Plexus Infusions

Role: lead

NCT01005992Phase 1Unknown

Fractional Photothermolysis for the Treatment of Burn Scars

Role: lead

All 5 trials loaded